e-learning
resources
Vienna 2003
Monday 29.09.2003
Clinical pathobiology in diffuse and in neoplastic disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The value of imunohistochemistry in pleural carcinosis
J. M. Stojsic, D. D. Jovanovic, L. D. Nagorni-Obradovic, A. S. Blanka (Beograd, Yugoslavia)
Source:
Annual Congress 2003 - Clinical pathobiology in diffuse and in neoplastic disorders
Session:
Clinical pathobiology in diffuse and in neoplastic disorders
Session type:
Thematic Poster Session
Number:
1688
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. M. Stojsic, D. D. Jovanovic, L. D. Nagorni-Obradovic, A. S. Blanka (Beograd, Yugoslavia). The value of imunohistochemistry in pleural carcinosis. Eur Respir J 2003; 22: Suppl. 45, 1688
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Related content which might interest you:
The value of thoracoscopy in malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 516s
Year: 2001
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
The diagnostic value of CA-125 in pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 386s
Year: 2001
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Is ²blind² pleural biopsy still of value in tuberculous effusions?
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
The value of mesothelin in pleural effusion vs histology by medical thoracoscopy
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions
Source: Annual Congress 2009 - Pleural diseases
Year: 2009
Value of pleural puncture in pleural effusions
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Diagnostic approach in a patient with pleural effusion
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131
Year: 2002
Diagnostic value of closed pleural needle biopsy for the diagnosis of malignant and tuberculous pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 446s
Year: 2005
Utility of closed pleural biopsy in the diagnosis of pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006
Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012
Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesothelioma
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
Transudative malignant pleural effusions
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019
Closed pleural brushing in the diagnosis of malignant pleural effusions
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
Closed pleural needle biopsy and pleural fluid examination in pathological diagnosis of malignant pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept